Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection.

Autor: Ullah TR; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia., Johansen MD; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia., Balka KR; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Ambrose RL; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia., Gearing LJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia., Roest J; St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia., Vivian JP; St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia., Sapkota S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia., Jayasekara WSN; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia., Wenholz DS; Noxopharm Limited, Chatswood, NSW, Australia.; School of Chemistry, UNSW Sydney, Kensington, NSW, Australia., Aldilla VR; School of Chemistry, UNSW Sydney, Kensington, NSW, Australia., Zeng J; MedChemSoft Solutions, Ferntree Gully, VIC, Australia., Miemczyk S; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia., Nguyen DH; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia., Hansbro NG; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia., Venkatraman R; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Kang JH; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Pang ES; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Thomas BJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia.; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC, Australia., Alharbi AS; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia.; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Turabah, Saudi Arabia., Rezwan R; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia., O'Keeffe M; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Donald WA; School of Chemistry, UNSW Sydney, Kensington, NSW, Australia., Ellyard JI; Department of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Wong W; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia., Kumar N; School of Chemistry, UNSW Sydney, Kensington, NSW, Australia., Kile BT; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia., Vinuesa CG; Department of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Francis Crick Institute, London, UK., Kelly GE; Noxopharm Limited, Chatswood, NSW, Australia., Laczka OF; Noxopharm Limited, Chatswood, NSW, Australia., Hansbro PM; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia., De Nardo D; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Gantier MP; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia. Michael.gantier@hudson.org.au.; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia. Michael.gantier@hudson.org.au.

Publikováno v: Nature communications [Nat Commun] 2023 Sep 18; Vol. 14 (1), pp. 5666. Date of Electronic Publication: 2023 Sep 18.

Mixing and Flow-Induced Silk Fibroin Self-Assembly in Microfluidic and Semi-Batch Nanoprecipitation

Autor: Yvonne Perrie, Matthew Sal, Rezwan R, Seib Fp

Here, we report the modulation of silk fibroin self-assembly by varying factors which control shear and mixing during nanoprecipitation in semi-batch and micro-mixers. For feeds processed at low shear in a semi-batch format, the properties of seconda

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d45322e209a7294aae75530321e8494
https://doi.org/10.26434/chemrxiv.14778393.v1

Correction: Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly.

Autor: Matthew SAL; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde 161 Cathedral Street Glasgow G4 0RE UK philipp.seib@strath.ac.uk +44 (0)141 548 2510., Rezwan R; Department of Pharmacy, ASA University Bangladesh 23/3 Bir Uttam A. N. M. Nuruzzaman Sarak Dhaka 1207 Bangladesh., Kaewchuchuen J; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde 161 Cathedral Street Glasgow G4 0RE UK philipp.seib@strath.ac.uk +44 (0)141 548 2510.; Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy Bangkok Thailand., Perrie Y; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde 161 Cathedral Street Glasgow G4 0RE UK philipp.seib@strath.ac.uk +44 (0)141 548 2510., Seib FP; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde 161 Cathedral Street Glasgow G4 0RE UK philipp.seib@strath.ac.uk +44 (0)141 548 2510.; EPSRC Future Manufacturing Research Hub for Continuous Manufacturing and Advanced Crystallisation (CMAC), University of Strathclyde, Technology and Innovation Centre 99 George Street Glasgow G1 1RD UK.

Publikováno v: RSC advances [RSC Adv] 2022 Sep 07; Vol. 12 (38), pp. 25006-25009. Date of Electronic Publication: 2022 Sep 07 (Print Publication: 2022).

Volumetric Scalability of Microfluidic and Semi-Batch Silk Nanoprecipitation Methods.

Autor: Matthew SAL; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK., Rezwan R; Department of Pharmacy, State University of Bangladesh, Dhaka 1205, Bangladesh.; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia., Perrie Y; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK., Seib FP; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.; EPSRC Future Manufacturing Research Hub for Continuous Manufacturing and Advanced Crystallisation (CMAC), University of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, UK.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2022 Apr 06; Vol. 27 (7). Date of Electronic Publication: 2022 Apr 06.

SAT-421 OUTCOME OF DACLATASVIR AND LOW DOSE SOFOSBUVIR IN HEPATITIS –C VIRUS INFECTION IN PATIENTS OF END STAGE RENAL DISEASE ON MAINTENANCE HEMODIALYSIS

Autor: Mostafi, M., Jabin, M., Rezwan, R., Khandakar Akhi, A.

Publikováno v: In Kidney International Reports March 2020 5(3) Supplement:S176-S176